Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging

Author(s):  
Domenico Albano ◽  
Federico Bruno ◽  
Andrea Agostini ◽  
Salvatore Alessio Angileri ◽  
Massimo Benenati ◽  
...  
2019 ◽  
Vol 14 (10) ◽  
pp. S800
Author(s):  
K. Suemori ◽  
M. Kataoka ◽  
D. Okutani ◽  
T. Fujita ◽  
I. Togami ◽  
...  

2016 ◽  
Vol 5 (1) ◽  
pp. 44-48 ◽  
Author(s):  
MINORU TOMIZAWA ◽  
FUMINOBU SHINOZAKI ◽  
KAZUNORI FUGO ◽  
TAKAFUMI SUNAOSHI ◽  
DAISUKE KANO ◽  
...  

2011 ◽  
Author(s):  
Jun Xia ◽  
Zijian Guo ◽  
Andres Aguirre ◽  
Quing Zhu ◽  
Lihong V. Wang

1986 ◽  
Vol 11 (10) ◽  
pp. 716-717 ◽  
Author(s):  
JEREMY J. HOLLERMAN ◽  
MARC A. BERNSTEIN ◽  
JERRY W. FROELICH ◽  
GEORGE SCHKUDOR

Author(s):  
Noriko Sato ◽  
Peter L. Choyke

AbstractIn the past decades, immunotherapies against cancers made impressive progress. Immunotherapy includes a broad range of interventions that can be separated into two major groups: cell-based immunotherapies, such as adoptive T cell therapies and stem cell therapies, and immunomodulatory molecular therapies such as checkpoint inhibitors and cytokine therapies. Genetic engineering techniques that transduce T cells with a cancer-antigen-specific T cell receptor or chimeric antigen receptor have expanded to other cell types, and further modulation of the cells to enhance cancer targeting properties has been explored. Because cell-based immunotherapies rely on cells migrating to target organs or tissues, there is a growing interest in imaging technologies that non-invasively monitor transferred cells in vivo. Here, we review whole-body imaging methods to assess cell-based immunotherapy using a variety of examples. Following a review of preclinically used cell tracking technologies, we consider the status of their clinical translation.


Sign in / Sign up

Export Citation Format

Share Document